NCT06674174

Brief Summary

Patients was selected based on inclusion and exclusion criteria. Experimental group was treated with Resistance training while control group received endurance training. Data was collected by spirometry and International Physical activity questionnaire readings was recorded in every session for baseline, 3rd week and 6thweeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2024

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2024

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

August 13, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
Last Updated

November 5, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

August 13, 2024

Last Update Submit

November 3, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Spirometry

    Spirometry is one of the Pulmonary Function Test; they are useful investigations in the management of patients with respiratory disease or respiratory weakness secondary to neurological impairment. They aid diagnosis, help monitor response to treatment and can guide decisions regarding further treatment and intervention. Spirometry can measure all the lung volumes except residual volume.

    6 weeks

  • International Physical Activity Questionnaire

    The International Physical Activity Questionnaire is a 27-item self-reported measure of physical activity for use with individual adult patients aged 15 to 69 years old. The International Physical Activity Questionnaire can be used clinically and in population research that compares physical activity levels between populations internationally.To calculate MET minutes a week multiply the MET value given (remember walking = 3.3, moderate activity = 4, vigorous activity = 8) by the minutes the activity was carried out and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET minutes for that activity are 3.3 X 30 X 5=495 Met minutes a week.

    6 weeks

Study Arms (2)

lower limb strength training

EXPERIMENTAL

Experimental group will receive lower limb strength training

Other: lower limb strength training

endurance training

OTHER

control group will receive endurance training.

Other: endurance training

Interventions

Experimental group will receive lower limb strength training treatment for three days a week and each session will last for an hour for 3 consecutivemonths. Measurement will be recorder pre-treatment and post treatment of both groupsat baseline,3rd, and 6th week.

lower limb strength training

Control group will receive endurance training, treatment for three days a week and each session will last for an hour for 3 consecutivemonths. Measurement will be recorder pre-treatment and post treatment of both groupsat baseline,3rd, and 6th week.

endurance training

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Young cigarette smokers (10 cigarette/day for at least 10 years)
  • Male
  • Age 25-45 years
  • Sedentary lifestyle
  • Body mass: less than 80kg
  • BMI:22-30

You may not qualify if:

  • Heart or pulmonary disease
  • MSK disorder
  • incapable of realizing the protocol of exercises,
  • Recent surgery
  • Recent Trauma.
  • Any infective respiratory illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samina International Hospital

Dera Ismāīl Khān, Pakistan

Location

MeSH Terms

Conditions

Smoking

Interventions

Endurance Training

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Maria Razzaq, MsCPPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2024

First Posted

November 5, 2024

Study Start

July 1, 2023

Primary Completion

July 15, 2024

Study Completion

July 18, 2024

Last Updated

November 5, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations